Skip to main content
. 2022 Mar 3;82(5):819–830. doi: 10.1158/0008-5472.CAN-21-1843

Figure 4.

Figure 4. SF3B1K700E-associated xenografts are sensitive to etoposide and olaparib. A, In vivo treatment schedule. Mice were randomly assigned to three different treatment groups: vehicle, olaparib, or etoposide. Treatments were administered as indicated. B, Fold change in tumor volume in mice from the different treatment groups described above. Mean fold change in tumor volumes from the 6 mice in each treatment condition is plotted ± SEM.

SF3B1K700E-associated xenografts are sensitive to etoposide and olaparib. A,In vivo treatment schedule. Mice were randomly assigned to three different treatment groups: vehicle, olaparib, or etoposide. Treatments were administered as indicated. B, Fold change in tumor volume in mice from the different treatment groups described above. Mean fold change in tumor volumes from the 6 mice in each treatment condition is plotted ± SEM.